A Study to Assess the Prevention of Bone-related Events in Patients With Bone Metastases From Malignant Solid Tumors Treated With JMT103 Compared to Zoledronic Acid
Clinical trial NCT06221072 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06221072
- Sponsor
- Shanghai JMT-Bio Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-05
- Primary completion
- 2027-05-31
- Enrollment
- 1360
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.